Individual del paciente basada en meta-análisis de lentinan para el cáncer gástrico resecable / recurrente

Categoría Resumen estructurado de revisiones sistemáticas
RevistaDatabase of Abstracts of Reviews of Effects (DARE)
Año 2012
CRD SUMMARY: This review based on individual patient data (650 patients) found a modest increase in overall survival rates in patients with advanced gastric cancer treated when a combination of fluorinated pyrimidines and lentinan was used compared with the chemotherapy alone. The results are likely to be reliable assuming that the small sample size did not limit generalisability.
Epistemonikos ID: 2ee7467c739d9a6154882bc872c2156d3bbb6369
First added on: Jun 07, 2012